Shasqi Is A Clinical Stage Biotechnology Company Based In San Franciscocaliforniafounded In 2015The Company Focuses On Developing Targeted Cancer Therapeutics Through Its Proprietary Capacclick Activated Protodrugs Against Cancerplatformthis Innovative Technology Utilizes Click Chemistry To Deliver High Doses Of Cancer Drugs Directly To Tumorsaiming To Reduce Side Effects And Enhance Treatment Effectiveness Shasqi S Primary Service Involves The Application Of Its Capac Platformwhich Allows For Both Intratumoral Injections And Systemic Administration Of Drugsnotablythe Company Has Successfully Demonstrated The Safe Delivery Of Doxorubicin At 12 Times The Standard Dose Directly To Tumorsadditionallyshasqi Has Developed A Protodrug Targeting Ceacam5Which Is Overexpressed In Several Types Of Cancerincluding Lung And Colorectal Cancersthe Company S Technology Is Intended For Use By Biopharmaceutical Companiesoncology Researchersand Healthcare Providers Involved In Cancer Treatment
